This public assessment report has been superseded by a more recent report published in 2015
29 October 2012
Pseudoephedrine and ephedrine are nasal decongestants (drugs which help to clear a blocked nose) contained in several over-the-counter cough and cold medicines.
There is a risk that pseudoephedrine and ephedrine can be extracted from the medicines and used in the illegal manufacture of the class A drug methylamphetamine (crystal meth). In 2008, legal measures were introduced in the UK to manage this risk of misuse. The measures included reduced pack sizes, and a tighter control on sales.
As with previous reviews, the 2012 review concluded that the measures are continuing to effectively manage the risk of misuse of pseudoephedrine or ephedrine. A Public Assessment Report which summarises the findings from the 2012 review is now available.
This report presents the evidence that was available when the regulatory decision was made, showing a ‘snapshot’ of the clinical landscape at the time. However, any advice in this report remains current unless it is superseded by a more recent report (where relevant, this is indicated).